30 May, 2022 The UK Supreme Court's CMA v Flynn decision is unlikely to change the Upper Tribunal's approach to costs against the financial services regulators By Duncan Campbell Recent legal commentary has exaggerated the practical implications of the UK Supreme Court's decision in CMA v Flynn Pharma [2022] UKSC...
